fda warning letters bpc 157 2023 NBC News | The claims surrounding peptides are sweeping: They're promoted as treatments for everything from faster healing to younger-looking skin, FDA to weigh easing limits
FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures The Washington Post FDA's Overreach on Compounded Peptides RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion BREAKING: The FDA just reversed theIR 2023 peptide ban. 12 peptides were just pulled from the Category 2 restricted list: 1. BPC 157 2. Thymosin beta 4 fragment (TB 500) 3. Epitalon 4. GHK Cu (injectable) This is the first vote from the FDA's Pharmacy Compounding Advisory Committee on one of 7 peptides up for consideration. While the committee advises through these votes, ultimately the FDA will make Unregulated Peptide Use in the Age of Biohacking: Digital Promotion, Gray Market Access, and Emerging Public Health Risks Cureus
Pay in 4 interest-free payments of $7.12 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 20 - Sep 25



